MedPath

Betta Pharmaceuticals Co.,Ltd

Ownership
-
Established
2003-01-07
Employees
1.8K
Market Cap
-
Website
www.bettapharma.com
Introduction

Established in 2003, the company is a high-tech pharmaceutical enterprise founded by a team of high-level talents returning from overseas, integrating R&D, production and marketing with independent intellectual property research and development as the core. On November 7, 2016, Betta Pharmaceuticals was listed on the Shenzhen Stock Exchange. The company is a national high-tech enterprise founded by Dr. Overseas Returning, with research and development of innovative drugs with independent intellectual property as the core, integrating R&D, production and marketing. The company's main products Kaimena, Bemena, Beantin, SEMENA, and Vomena are chemical pharmaceuticals. Corporate honors: Chairman Ding Lieming won the title of “Outstanding Person in the Overseas Chinese Community”; Gao Yaqin, the company's senior QC commissioner, won the National May 1st Labor Medal; Chairman Ding Lieming won the Zhejiang Science and Technology Significant Contribution Award; Beida Pharmaceutical won the first “Four Strong Provinces” leading enterprise in Zhejiang; Dr. Ding Lieming won the first “Global Zhejiang Gold Award”, etc.

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

Rice Bran Sterol Tablets

Product Name
糠甾醇片
Approval Number
国药准字H33022402
Approval Date
Sep 9, 2024
NMPA

烧伤止痛膏

Approval Number
国药准字Z20030005
Approval Date
Sep 9, 2024
NMPA

虎参软膏

Approval Number
国药准字B20020818
Approval Date
Sep 6, 2024
NMPA

Oryzaol、Vitamin Bland Vitamin B6 Tablet

Product Name
谷维素双维B片
Approval Number
国药准字H33022115
Approval Date
Sep 3, 2024
NMPA

Orzanol Tablets

Product Name
谷维素片
Approval Number
国药准字H33022513
Approval Date
Sep 3, 2024
NMPA

Vitamin B2 Tablets

Product Name
维生素B2片
Approval Number
国药准字H33022516
Approval Date
Sep 3, 2024
NMPA

Vitamin B2 Tablets

Product Name
维生素B2片
Approval Number
国药准字H33022515
Approval Date
Sep 3, 2024
NMPA

Befotertinib Mesylate Capsules

Product Name
赛美纳
Approval Number
国药准字H20230012
Approval Date
Sep 28, 2023
NMPA

Befotertinib Mesylate Capsules

Product Name
赛美纳
Approval Number
国药准字H20230011
Approval Date
Sep 28, 2023
NMPA

Vorolanib Tablets

Product Name
伏美纳
Approval Number
国药准字H20230013
Approval Date
Jun 7, 2023
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.